text size:
New Delhi: The company’s CEO Adar Poonawalla on Tuesday said that Serum Institute of India (SII) is planning to launch a COVID vaccine for children in the next six months.
Participating in an industry conference, Poonawalla said that the vaccine ‘Kovovax’ is under trial and will provide protection to children below the age of three years.
Currently, Covishield and other COVID vaccines are approved for people over the age of 18.
“We have not seen very severe disease in children. Fortunately, there is no panic for children. However, we will launch a vaccine in six months for children, hopefully by the age of three,” Poonawalla said.
He said there are already two companies in India that have licenses and their vaccines will be available soon.
“I think yes, you should get your kids vaccinated. There’s no harm, these vaccines have been proven to be safe and effective and all that. But wait for the official announcements and go ahead with it.
“Our vaccine Kovovax will be launched for children in six months,” Poonawalla said, adding that Kovovax is under trial and has shown excellent data all the way to the three-year age group.
In addition, Poonawalla said there is enough data to show that vaccines will work and protect children from infectious disease.
As of now, nothing can be said about the Omicron version as to how it will affect children, he said.
“I don’t know what will happen with Omicron, but so far the kids have not been affected too badly by this (Covid) virus. I think his body, his cells and his lungs heal better.”
subscribe our channel youtube And Wire
Why is the news media in crisis and how can you fix it?
India needs independent, unbiased, non-hyphenated and questionable journalism even more as it is facing many crises.
But the news media itself is in trouble. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, crude prime-time spectacle.
ThePrint has the best young journalists, columnists and editors to work for it. Smart and thinking people like you will have to pay a price to maintain this quality of journalism. Whether you live in India or abroad, you can Here,